Matinas BioPharma Inc. (MTNB)
AMEX: MTNB
· Real-Time Price · USD
2.31
0.66 (40.00%)
At close: Aug 15, 2025, 3:59 PM
2.42
4.99%
After-hours: Aug 15, 2025, 07:58 PM EDT
Matinas BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 962K | n/a | n/a | n/a | -1.1M | n/a | n/a | 1.1M | 1.06M | 1.06M | 1.06M | n/a | -33.3K | n/a | n/a | 33.33K |
Cost of Revenue | n/a | n/a | n/a | 241K | 240K | 240K | 238K | 234K | 229K | 3.49M | 230.79K | 229.86K | 211.53K | 1.33M | 196.04K | 182.79K | 3.24M |
Gross Profit | n/a | n/a | n/a | -241K | -240K | -1.34M | -238K | -234K | 867K | -2.43M | 831.71K | 832.64K | -211.53K | -1.36M | -196.04K | -182.79K | -3.21M |
Operating Income | -1.95M | -4.04M | -4.38M | -5.84M | -5.9M | -5.89M | -6.13M | -6.16M | -5.59M | -5.48M | -5.46M | -5.93M | -7.72M | -6.71M | -6.88M | -4.79M | -6.35M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.66M | -8.51M | -4.28M | -5.72M | -5.82M | -5.31M | -6.05M | -6.06M | -5.51M | -3.63M | -5.46M | -5.92M | -5.98M | -6.7M | -6.84M | -4.79M | -4.96M |
Net Income | -1.66M | -8.43M | -4.28M | -5.72M | -5.82M | -5.31M | -6.05M | -6.06M | -5.44M | -32.56K | -5.46M | -5.92M | -2.5M | -6.7M | -6.84M | -4.79M | -4.96M |
Selling & General & Admin | 1.86M | 1.66M | 2.14M | 2.47M | 2.22M | 1.98M | 2.84M | 2.6M | 2.71M | 2.68M | 2.82M | 2.86M | 2.74M | 2.47M | 2.26M | 2.31M | 3.15M |
Research & Development | 85K | 2.38M | 2.24M | 3.37M | 3.45M | 3.67M | 3.29M | 3.56M | 3.97M | 3.87M | 3.71M | 4.13M | 4.98M | 4.24M | 4.62M | 2.48M | 3.24M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 79K | 99K | 73K | 88.25K | 988.00 | 2.87K | 9.89K | 14.57K | 41.39K | -1.42K | 68.32K |
Operating Expenses | 1.95M | 3.79M | 4.38M | 5.84M | 5.66M | 5.65M | 6.13M | 6.16M | 6.68M | 6.54M | 6.53M | 6.99M | 7.72M | 6.71M | 6.88M | 4.79M | 6.39M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -240K | -240K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.95M | 8.47M | 4.38M | 5.84M | 5.9M | 5.89M | 6.13M | 6.16M | 6.68M | 6.54M | 6.53M | 6.99M | 7.72M | 6.71M | 6.88M | 4.79M | 6.39M |
Income Tax Expense | n/a | -80K | n/a | n/a | n/a | n/a | n/a | n/a | -73K | -3.6M | -988 | -2.87K | -3.48M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 5.09M | 4.87M | 5.04M | 4.99M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.34M | 4.34M | 4.34M | 4.33M | 4.33M | 4.3M | 4.1M | 4.08M |
Shares Outstanding (Diluted) | 5.09M | 4.87M | 5.04M | 4.99M | 4.35M | 4.35M | 4.35M | 4.35M | 4.35M | 4.34M | 4.34M | 4.34M | 4.33M | 4.33M | 4.3M | 4.1M | 4.08M |
EPS (Basic) | -0.33 | -1.73 | -0.85 | -1.15 | -1.34 | -1.22 | -1.39 | -1.39 | -1.25 | -0.01 | -1.26 | -1.36 | -0.58 | -1.55 | -1.59 | -1.17 | -1.22 |
EPS (Diluted) | -0.33 | -1.73 | -0.85 | -1.15 | -1.34 | -1.22 | -1.39 | -1.39 | -1.25 | -0.01 | -1.26 | -1.36 | -0.58 | -1.55 | -1.59 | -1.17 | -1.22 |
EBITDA | -1.95M | -3.79M | -4.14M | -5.6M | -5.66M | -5.7M | -5.9M | -5.83M | -5.28M | -5.38M | -5.23M | -5.69M | -7.65M | -6.49M | -6.64M | -4.61M | -6.28M |
EBIT | n/a | -4.04M | -4.38M | -5.84M | -5.9M | -5.89M | -6.13M | -6.16M | -5.59M | -5.48M | -5.46M | -5.92M | -7.72M | -6.71M | -6.88M | -4.79M | -6.35M |
Depreciation & Amortization | n/a | 247K | 244K | 241K | 240K | 240K | 238K | 234K | 229K | 225.82K | 230.79K | 229.86K | 211.53K | 205.11K | 196.04K | 182.79K | 197.56K |